AMERISAFE, Inc.
Financial ServicesNASDAQ:AMSF · NASDAQ Global Select
-$0.27 today
Vol 0.14M · Avg 0.23M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$324.8M of revenue converted into $46.3M of net income for the selected period. Gross margin is 47.6% and net margin is 14.3%, showing how much revenue survives after costs and taxes. EPS is $2.43, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $317.3M +2.6% | $309.1M +0.7% | $306.9M +4.1% | $294.7M -6.7% | $316.0M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $169.9M -6.1% | $181.0M | $0 -100.0% | $152.3M -5.3% | $160.8M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $147.3M +15.0% | $128.1M -58.3% | $306.9M +115.6% | $142.4M -8.3% | $155.2M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 46.4% +5.0pp | 41.4% -58.6pp | 100.0% +51.7pp | 48.3% -0.8pp | 49.1% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $0 -100.0% | $31.5M +15.1% | $27.4M +3.2% | $26.5M +2.1% | $26.0M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $88.5M +49.8% | $59.0M -74.3% | $229.5M +207.1% | $74.7M -1.4% | $75.8M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $742.0K -32.1% | $1.1M -23.4% | $1.4M +9.0% | $1.3M +28.7% | $1.0M | $374.2M | $1.2B | $631.8M |
| EBITDA | $59.6M -15.0% | $70.1M | $0 -100.0% | $69.0M -14.3% | $80.5M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 18.8% -3.9pp | 22.7% | 0.0% -23.4pp | 23.4% -2.1pp | 25.5% | 5.6% | 46.3% | 42.0% |
| Operating Income | $58.9M -14.8% | $69.1M -10.8% | $77.4M +14.4% | $67.6M -14.9% | $79.4M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 18.6% -3.8pp | 22.3% -2.9pp | 25.2% +2.3pp | 23.0% -2.2pp | 25.1% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $0 | $0 | $0 | $0 | $0 | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $58.9M -14.8% | $69.1M -10.8% | $77.4M +14.4% | $67.6M -14.9% | $79.4M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 18.6% -3.8pp | 22.3% -2.9pp | 25.2% +2.3pp | 23.0% -2.2pp | 25.1% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $11.7M -14.1% | $13.6M -10.8% | $15.3M +26.8% | $12.0M -12.0% | $13.7M | $1.3B | -$1.6B | $745.2M |
| Net Income | $47.1M -15.0% | $55.4M -10.7% | $62.1M +11.7% | $55.6M -15.4% | $65.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | 14.9% -3.1pp | 17.9% -2.3pp | 20.2% +1.4pp | 18.9% -1.9pp | 20.8% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $2 -14.8% | $3 -10.2% | $3 +12.1% | $3 -15.0% | $3 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $2 -14.5% | $3 -10.5% | $3 +12.2% | $3 -15.0% | $3 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $19.0M -0.5% | $19.1M -0.4% | $19.1M -0.4% | $19.2M -0.5% | $19.3M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $19.1M -0.4% | $19.2M -0.3% | $19.2M -0.5% | $19.3M -0.4% | $19.4M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Protector Forsikring ASA
PSKRF
$3.96B
Trisura Group Ltd.
TRRSF
$1.44B
Employers Holdings, Inc.
NYSE:EIG
$1.02B
Tiptree Inc.
NASDAQ:TIPT
$665.74M
Hippo Holdings Inc.
NYSE:HIPO
$664.96M
Investors Title Company
NASDAQ:ITIC
$479.00M
Ambac Financial Group, Inc.
AMBC
$397.37M
MBIA Inc.
NYSE:MBI
$314.26M
First Acceptance Corporation
FACO
$199.26M
James River Group Holdings, Ltd.
NASDAQ:JRVR
$193.73M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does AMSF generate?
AMERISAFE, Inc. (AMSF) reported $317.25M of revenue in fiscal 2025.
Is AMSF profitable?
AMERISAFE, Inc. (AMSF) reported $47.15M of net income, with a net margin of 14.9%.
Explore More
Continue the stock analysis
Jump to another research area for this company.